Glomerular Disease Management
Nephrology
Starting from
$2,000
Up to $10,000 depending on centre
Typical duration
7–21 days
Including pre-operative work-up
Content reviewed for medical accuracy by: Dr. Rodina Ainasoa · Medical Content Writer & Health Communications
Overview
Expert diagnosis and treatment of glomerulonephritis and nephrotic syndrome through kidney biopsy, immunosuppressive therapy, and specialist nephrology follow-up at internationally accredited centers. International patients gain access to experienced nephrologists and pathologists who manage rare conditions often under-diagnosed in their home countries.
Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.
What's included
Glomerular Disease Management
Indicative coordinated cost from
or message us on WhatsApp
No commitment required. Your information is shared only with authorised parties involved in your care coordination, subject to applicable privacy requirements.
Key insights at a glance
Starting from
$2,000
Up to $10,000 depending on centre
Typical duration
7–21 days
Including pre-operative work-up
Procedures
3
Hold to see procedures
Partner hospitals
0
Vetted for outcome data & accreditation
Conservative Management vs. Immunosuppressive Therapy
Glomerular diseases are treated very differently depending on the specific diagnosis found on kidney biopsy. Here is how a conservative, supportive approach compares with immunosuppressive therapy for more active disease.
| Parameter | Conservative / Supportive Management | Immunosuppressive Therapy |
|---|---|---|
| Primary goal | Protect kidney function and control symptoms — blood pressure, swelling, protein loss — without suppressing the immune system. | Suppress the underlying immune-mediated injury to the kidney's filtering units and induce disease remission. |
| Typical candidates | Milder or non-progressive presentations, such as low-level proteinuria with preserved kidney function, or biopsy findings showing limited active inflammation. | More active or progressive disease on biopsy — for example lupus nephritis, ANCA-associated vasculitis, or FSGS and minimal change disease with heavy proteinuria. |
| Core measures | ACE inhibitors or ARBs to reduce proteinuria and control blood pressure, SGLT2 inhibitors where appropriate, dietary sodium restriction, and diuretics for swelling. | Corticosteroids combined with agents such as mycophenolate mofetil, cyclophosphamide, calcineurin inhibitors, rituximab, or belimumab depending on the specific diagnosis, per KDIGO guidance. |
| Monitoring intensity | Periodic blood pressure, urine protein, and kidney function checks, typically every few months. | Frequent early monitoring — often monthly or more — for treatment response, infection risk, and medication side effects, tapering in frequency as disease stabilizes. |
| Key trade-off | Lower risk of medication side effects, but may not halt disease progression if underlying inflammation is active. | Greater chance of inducing remission in active disease, but carries meaningful risks of infection and other side effects that must be weighed against expected benefit. |
The Clinical Management Process: Step by Step
The steps below outline a typical pathway for diagnosing and managing a glomerular disease. Your nephrologist will confirm the exact plan based on your biopsy result and specific diagnosis.
Diagnostic workup and kidney biopsy
Blood and urine tests, imaging, and a percutaneous kidney biopsy performed under ultrasound guidance are used to determine the specific glomerular disease affecting you, since treatment differs significantly by diagnosis.
Pathology review and treatment planning
A nephropathologist examines the biopsy tissue under light microscopy, immunofluorescence, and electron microscopy, and your nephrologist uses this result to build a treatment plan tailored to your specific condition, such as IgA nephropathy, FSGS, membranous nephropathy, or lupus nephritis.
Initiating therapy
Depending on the diagnosis and severity, therapy may involve supportive medications alone, or immunosuppressive treatment such as corticosteroids and steroid-sparing agents, introduced under close supervision to manage side effects.
Monitoring response and adjusting treatment
Regular blood and urine tests track how well the kidneys are responding, allowing your nephrologist to adjust medication doses, watch for relapse, and screen for treatment-related complications over time.
Ongoing Monitoring & Management Timeline
Early follow-up focuses on confirming the biopsy diagnosis, starting the treatment plan, and monitoring for immediate medication side effects or biopsy-related complications, per National Kidney Foundation guidance.
Urine protein and kidney function are checked frequently to assess early treatment response; immunosuppressive doses are commonly adjusted during this period based on how the disease is responding.
For many glomerular diseases, this is when remission — partial or complete — becomes evident, per KDIGO guidance; medication tapering may begin if the disease has responded well, while non-responders may need a change in therapy.
Ongoing nephrology follow-up continues indefinitely for most patients, since relapse is possible and long-term kidney function must be tracked, even after successful treatment.
Source: National Kidney Foundation; KDIGO 2021/2024/2025 Clinical Practice Guidelines for the Management of Glomerular Diseases; Mayo Clinic; Cleveland Clinic. Individual monitoring plans vary and are guided by your treating nephrologist.
Known Risks & Limitations
- Immunosuppressive therapy carries a meaningful risk of infection, and can also cause side effects such as bone density loss, blood sugar changes, or blood count changes, depending on the specific agents used, per KDIGO guidance.
- Glomerular diseases are a diverse group of conditions, and outcomes vary significantly by specific diagnosis — IgA nephropathy, minimal change disease, FSGS, membranous nephropathy, and lupus nephritis each carry a different expected disease course and treatment response.
- Relapse after an initial response to treatment is possible for many glomerular diseases and may require repeat or adjusted immunosuppressive therapy.
- Despite appropriate treatment, some glomerular diseases can still progress to chronic kidney disease or, in a minority of cases, kidney failure requiring dialysis or transplantation, per National Kidney Foundation data.
- Long-term nephrology follow-up is important even after apparent remission, since disease activity and kidney function can change over years, and some treatment side effects only emerge with prolonged use.
Source: National Kidney Foundation; KDIGO Clinical Practice Guidelines for the Management of Glomerular Diseases; Mayo Clinic; Cleveland Clinic. No treatment is without risk; your treating nephrologist will review your individual case.
The CureSureMedico Care Pathway
Remote case review
Share your prior test results, urine and blood work, and any imaging with our coordination team, who forward your case for an initial nephrology review of whether a kidney biopsy or further workup is likely to change your management.
Nephrologist and pathologist matching
We match you with an accredited nephrology center experienced in glomerular disease diagnosis, including on-site nephropathology capable of light microscopy, immunofluorescence, and electron microscopy review.
Cost estimate and travel planning
Once your case is reviewed, we issue a consolidated cost estimate covering consultation, biopsy, pathology, and initial treatment, and help plan a trip length that allows time for biopsy results and treatment initiation.
Biopsy, diagnosis, and treatment initiation
You undergo the kidney biopsy and initial workup, receive your diagnosis and treatment plan from your nephrologist, and begin therapy under close monitoring before you travel home.
Long-term follow-up and continuity of care
Before you depart, your biopsy report, diagnosis, and treatment plan are shared with your home-country nephrologist so they can continue monitoring and adjusting your care over the long term.
Global cost comparison — Glomerular Disease Management
Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.
| Country | Avg. cost | vs. cheapest |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $3,000 | —chevron_right |
🇹🇷 Turkey Istanbul | $5,000 | +67%chevron_right |
Costs are indicative estimates and vary by procedure specifics, hospital, and clinical complexity. Request a personalised estimate for your specific case.
Similar procedures
Kidney Stone Treatment
Minimally invasive procedures to fragment and remove kidney stones, selected according to stone size, location, and composition.
Starting from
$1,000
3–7 days
Dialysis (Hemodialysis & Peritoneal)
Comprehensive dialysis services including initiation of hemodialysis (HD) and peritoneal dialysis (PD), vascular access creation, and patient training for self-managed dialysis — enabling end-stage renal disease patients to access affordable, high-quality renal replacement therapy abroad. India and Turkey offer JCI-accredited dialysis centers with the latest equipment at dramatically lower session costs.
Starting from
$500
14–30 days
Chronic Kidney Disease Management
Structured, specialist-led management for patients with CKD stages 3–5, focused on slowing disease progression, managing complications (anemia, bone disease, hypertension), and optimizing preparation for renal replacement therapy. Access experienced nephrologists at accredited centers in India and Thailand for a fraction of the cost of equivalent care in Europe or North America.
Starting from
$1,500
5–14 days
Pediatric Nephrology
Specialist renal care for infants, children, and adolescents with nephrotic syndrome, urinary tract anomalies, pediatric CKD, and dialysis needs, delivered by dedicated pediatric nephrologists at accredited children's hospitals. Families from regions with limited pediatric kidney expertise travel to India and Thailand for internationally recognized care at accessible costs.
Starting from
$1,500
7–21 days
Frequently asked questions
A percutaneous kidney biopsy performed under ultrasound guidance by an experienced interventional nephrologist or radiologist is safe, with major complication rates (significant bleeding requiring transfusion or intervention) below 1% at high-volume centers. The procedure itself takes 20–30 minutes under local anesthesia with light sedation. Post-procedure, you are monitored for 6–12 hours in a day-care or ward setting. Most patients are discharged the same day or the following morning. We recommend remaining in the country for at least 3 days post-biopsy to allow for monitoring and initial histopathology results. Full electron microscopy results typically take 5–7 days, and final reporting with treatment recommendations is provided before you depart or sent electronically.
Transparent fees. No commitment.
Clear, transparent guidance
CureSureMedico charges a transparent, fixed coordination fee to the patient or institutional payer. Treatment costs are billed directly by the partner hospital.